Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 7, 2005, Pages 1102-1108

  Okamoto, Kinya ^a   Mimura, Kenichi ^a   Murawaki, Yoshikazu ^a   Yuasa, Isao ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Genotype; Liver fibrosis; MMP 1; MMP 3; MMP 9

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMAN; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; ALLELES; DISEASE PROGRESSION; DNA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES;

EID: 21844458208     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03860.x     Document Type: Article

References (33)

1. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36: S47-56.
2. Powell EE, Edwards-Smith CJ, Hay JL et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-33.
3. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003; 37: 493-503.
4. Friedman SL. Hepatic fibrosis. In: Schiff ER, ed. Schiff's Diseases of the Liver, Ninth Edition. Philadelphia: Lippincott Williams and Wilkins, 2003; 409-27.
5. Nagase H, Woessner JF. Matrix metalloproteinases. J. Biol. Chem. 1999; 274: 21491-4.
6. Ye S. Polymorphism in matrix metalloproteinase gene promoters implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 2000; 19: 623-9.
7. Rutter JL, Mitchell TI, Buttice G et al. Single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998; 58: 5321-5.
8. Fujimoto T, Parry S, Urbanek M et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J. Biol. Chem. 2002; 277: 6296-302.
9. Ye S, Watts GF, Mandalia S et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Brit. Heart J. 1995; 73: 209-15.
10. Ye S, Eriksson P, Hamsten A et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 1996; 271: 13055-60.
11. Zhang B, Ye S, Herrmann S-M et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788-94.
12. Humphries SE, Luong LA, Talmud PJ et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis 1998; 139: 49-56.
13. Ghilardi G, Biondi ML, MeMonti M et al. Matrix metalloproteinase-1 and Matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002; 33: 2408-12.
14. Yoon S, Tromp G, Vongpunsawad S et al. Genetic analysis of the MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem. Biophys. Res. Commun. 1999; 265: 563-8.
15. Zhang B, Dhillon S, Geary I et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 2001; 32: 2198-202.
16. Kanamori Y, Matsushima M, Minaguchi T et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 1999; 59: 4225-7.
17. Nishioka Y, Kobayashi K, Sagae S et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endmetrial carcinomas. Jpn J. Cancer Res. 2000; 91: 612-15.
18. Ghilardi G, Biondi ML, Caputo M et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res. 2002; 8: 3820-3.
19. Ye S, Dhillon S, Turner SJ et al. Invasiveness of cutaneous malignant melanoma is influenced ty matrix metalloproteinase 1 gene polymorphism. Cancer Res. 2001; 61: 1296-8.
20. Zhu Y, Spitz MR, Lei L et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001; 61: 7825-9.
21. Hinoda Y, Okayama N, Takano N et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int. J. Cancer 2002; 102: 526-9.
22. Ghilardi G, Biondi ML, Mangoni J et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 2001; 7: 2344-6.
23. Cho HJ, Chae IH, Park KW et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J. Hum. Genet. 2002; 47: 88-91.
24. Satsangi J, Chapman RWG, Haldar N et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 2001; 121: 124-30.
25. Selmi C, Zuin M, Meda F et al. Common variants of the matrix metalloproteinase-3 (stromelysin) gene promoter in primary biliary cirrhosis. Gastroenterology 2002; 122: 248-9.
26. Dunleavey L, Beyyzade L, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol. 2000; 19: 175-7.
27. Gnasso A, Motti C, Irace C et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1600-5.
28. Nelissen I, Vandenbroeck K, Fiten P et al. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. J. Neuroimmunol. 2000; 105: 58-63.
29. Takahashi M, Haro H, Wakabayashi Y et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J. Bone. Joint Surg. Br. 2001, 83-B: 491-5.
30. Minematsu N, Nakamura H, Tateno H et al. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem. Biophys. Res. Commun. 2001; 289: 116-19.
31. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev. Eukaryot. Gene Expr. 1997; 7: 159-78.
32. Sciavolino PJ, Lee TH, Vilcek J. Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. J. Biol. Chem. 1994; 269: 21627-34.
33. Sirum KL, Brinckerhoff CE. Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts. Biochemistry 1989; 28: 8691-8.